MaxCyte, Inc. Reports Results for Quarter Ended June 30, 2026

What Happened

• On August 12, 2026, MaxCyte, Inc. issued a press release announcing its financial results for the quarter ended June 30, 2026 (furnished as Exhibit 99.1 to the Form 8-K). The company also posted an updated corporate presentation to its investor website (furnished as Exhibit 99.2). The Form 8-K was signed by CFO Parmeet Ahuja on August 12, 2026.
• The filing states these materials are "furnished" (not "filed") under the Securities Exchange Act, meaning they are included for disclosure but are not subject to the liability provisions of Section 18 and are not automatically incorporated by reference into other SEC filings.

Key Details

• Date of disclosure: August 12, 2026.
• Period covered: quarter ended June 30, 2026.
• Exhibits: Press release (Exhibit 99.1) and corporate presentation (Exhibit 99.2) posted to https://investors.maxcyte.com.
• Form 8-K signed by Parmeet Ahuja, Chief Financial Officer.

Why It Matters

• This 8-K signals that the company has released its latest quarterly results — investors should review the press release and the updated presentation for revenue, earnings, cash flow, guidance, clinical or commercial milestones, and any commentary from management.
• Because the materials are furnished (not filed), they are for disclosure and reference; investors should read the exhibits themselves (on the company website or SEC EDGAR) to see the detailed financial and operational metrics that could affect the stock.